19/04/2024 -
The partnership leverages Variant Bio’s genomic discovery capabilities and VB-Inference platform as well as Evotec’s expertise in antifibrotic drug discovery.
19/04/2024 -
Will also co-develop new DELs with an emphasis on novel chemical diversity and drug-likeness to further strengthen their service offering.
19/04/2024 -
Johnson will lead global operations for all Kindeva’s manufacturing, research, and development facilities located across the U.S. and U.K.